Table 2.

Effect of CAR treatment on liver SOD, CAT, and GSH-Px activities and MDA levels in cerulein-induced AP

Groups	SOD (U/mg protein)	CAT (U/mg protein)	GPx (U/mg protein)	MDA (nmol/mg protein)
Control	31.09 ± 0.17	3.02 ± 0.27	1.01 ± 0.13	6.95 ± 0.90
AP	17.45 ± 0.12*a	0.52 ± 0.22*a	0.22 ± 0.10*a	15.25 ± 0.30*a
CAR 50 mg/kg	32.31 ± 1.18b	3.17 ± 0.20b	1.20 ± 0.17b	6.90 ± 0.10b
CAR 100 mg/kg	32.80 ± 1.30b	3.67 ± 0.26b	1.25 ± 0.21b	6.87 ± 0.16b
CAR 200 mg/kg	35.40 ± 1.44b	4.43 ± 0.25b	1.57 ± 0.09b	6.89 ± 0.24b
AP + CAR 50 mg/kg	17.91 ± 0.31*a	1.05 ± 0.32*a	0.55 ± 0.12*a	14.96 ± 0.12*a
AP + CAR 100 mg/kg	18.24 ± 0.42*a	1.59 ± 0.28*a	0.60 ± 0.09*a	14.41 ± 0.26*a
AP + CAR 200 mg/kg	30.87 ± 0.89b	2.91 ± 0.17b	0.92 ± 0.11b	7.93 ± 0.15b

Data are presented as mean ± SD (n = 7)

* Symbole < 0.05 represents significant difference among the groups compared to controls. p < 0.05, significantly different from ^a Control group

^bAP group by Duncan’s Multiple Range post hoc tests for multiple comparisons of control and experimental groups